Abstract:The COVID-19 pandemic has been characterized by a lack of clear evidence to guide healthcare professionals, the public and policymakers. The resulting uncertainty, coupled with changing guidelines as additional evidence became available, added to the stress and anxiety reported by decision-makers. Research results are key to providing evidence to guide healthcare decisions. Important questions have arisen about whether various interventions are safe and effective. The evidence found guides those making treatment decisions, and influences those selecting interventions for further evaluation in research studies. As the COVID-19 pandemic intensified, the effectiveness and safety of many pharmaceuticals was queried. Ivermectin will be used to explore the ethics of how healthcare evidence must be critically appraised, even, or especially, during a pandemic. This drug is alleged to be effective in treating COVID-19, with various studies and systematic reviews finding supportive evidence. Some of these have now been linked to concerns about fraud or poor research reporting. This article will focus on the scientific literature and how apparently fraudulent studies were published and influenced treatment decisions, on-going research and public health guidelines. Research evidence is critical during emergencies like pandemics, but urgency should not overtake ethical responsibilities to critically appraise (or evaluate) studies as they become available. These responsibilities apply in various ways to editors, peer-reviewers, news media reporters, and those making treatment decisions, including clinicians, policymakers and the general public. While research article authors have the primary ethical responsibility to reject fraudulent or inaccurate claims, the readers of health research must carefully evaluate all publications. To detect and reject fraudulent healthcare claims, readers need critical appraisal skills that match their level of engagement with those articles. The core principles of critical appraisal will be described in the article, and how they can be adapted for different types of readers. Exemplar tools that develop critical appraisal skills will be noted, with reviews of ivermectin's efficacy explored as examples. As stakeholders in healthcare evidence are increasingly able to identify well-conducted and ethical research they will simultaneously be able to spot and reject fraudulent reports and prevent them from influencing healthcare decisions.

Repurposing Drugs to Treat Novel Infections: A Proposal for a Decision-Making Framework for Clinicians

Ivermectin and the Integrity of Healthcare Evidence During COVID-19

Making Drug Approval Decisions in the Face of Uncertainty: Cumulative Evidence versus Value of Information

Drug Repurposing in the Chemotherapy of Infectious Diseases

A review on drug repurposing in COVID-19: from antiviral drugs to herbal alternatives

Exploring Repurposing Potential of Existing Drugs in the Management of COVID-19 Epidemic: A Critical Review

Effective Treatment of COVID-19 Infection with Repurposed Drugs: Case Reports

Repurposed Drugs during the Outbreak of Pandemic COVID-19: A Mini-Review on Their Molecular Structures and Hit-and-Trial Results

Are we there yet? Analyzing scientific research related to COVID-19 drug repurposing

Drug repurposing for respiratory infections

Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies

Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes

Network medicine framework for identifying drug-repurposing opportunities for COVID-19

Weapons and Strategies against COVID-19: A Perspective

In silico Potential of Approved Antimalarial Drugs for Repurposing Against COVID-19

Drug Repurposing: An Effective Tool in Modern Drug Discovery

Drug repurposing: a systematic review on root causes, barriers and facilitators

Preclinical and Clinical Investigations of Potential Drugs and Vaccines for COVID-19 Therapy: A Comprehensive Review With Recent Update

Considerations for prioritising clinical research using bacteriophage

Drug Repurposing: A Leading Strategy for New Threats and Targets

Repurposing Approved Drugs for Guiding COVID-19 Prophylaxis: A Systematic Review